Aims-To investigate the pattern oftelomerase activity in hydatidiform mole as compared with normal placenta and choriocarcinoma, and to determine the prognostic significance of telomerase activity in hydatidiform mole. Methods-Telomerase activity in 35 cases of hydatidiform mole, 35 normal placentas, one choriocarcinoma sample, and two choriocarcinoma cell lines (JAR, JEG3) was determined using the sensitive polymerase chain reaction based telomeric repeat amplification protocol (TRAP) assay. Two cases of breast carcinoma and two cases of ovarian carcinoma were also included as positive controls in the telomerase assay.
was determined using the sensitive polymerase chain reaction based telomeric repeat amplification protocol (TRAP) assay. Two cases of breast carcinoma and two cases of ovarian carcinoma were also included as positive controls in the telomerase assay.
Results-Telomerase activity was detected in 11 of 30 early placentas (36.7%), one of five term placentas (20%), five of 27 hydatidiform moles which regressed spontaneously (18.5%), and six of eight hydatidiform moles which developed persistent trophoblastic disease (75%) (including three which developed metastases). Hydatidiform moles which subsequently developed persistent disease, especially those which metastasised, were more likely to express telomerase activity (p < 0.01). However, there was no significant difference in the frequency oftelomerase activity between early placentas and hydatidiform mole. Strong telomerase activity was observed in choriocarcinoma tissue, choriocarcinoma cell lines, and ovarian and breast carcinomas. Conclusions-Telomerase activation occurs in hydatidiform mole with a similar incidence to early normal placentas. This supports the concept that hydatidiform mole is essentially an abnormal conceptus. There is an association between telomerase activation and the development of persistent trophoblastic disease.
Further study is warrant to confirm the prognostic significance of telomerase activity in hydatidiform mole. (7 Clin Pathol 1999; 52:588-592) Keywords: telomerase activity; gestational trophoblastic disease; hydatidiform mole Repetitive telomere sequences are present at the ends of eukaryotic chromosomes which protect the ends from damage and rearrangements. Progressive shortening of telomeric sequences is associated with cell division owing to the end replication problem involved in DNA replication. Telomerase is a special type of reverse transcriptase which stabilises the telomeric ends of human chromosomes by adding the TTAGGG repeats onto the chromosome ends. Most normal somatic cells lack telomerase activity, and successive cell division will result in progressive shortening of telomeres leading to chromosomal instability. Telomere shortening, both in vivo and in vitro, has been postulated to be the mitotic clock counting the number of mitoses that the cells have undertaken. Excessive shortening of telomeric length may trigger the onset of cell senescence. The telomeres of tumour cells have to be maintained in order to sustain their continuous proliferative capacities, and telomerase is commonly activated in human tumours for this purpose.' 2 The placenta is a dynamic organ with programmed proliferation and differentiation of trophoblasts whose proper function is important for maintaining a successful pregnancy. Abnormal proliferation of trophoblasts may result in gestational trophoblastic disease which encompasses a heterogeneous group of lesions including hydatidiform mole, choriocarcinoma, and placental site trophoblastic tumour.3 These lesions are unique, since they can be considered as allografts arising from a conceptus that invades the maternal tissues.
Significant differences in morphology and clinical behaviour have been documented in these closely related entities. Some of these lesions, such as choriocarcinoma and placental site trophoblastic tumour, are definitely neoplastic, while hydatidiform moles may just be abnormal placentas that are prone to malignant transformation. Hydatidiform mole is diagnosed histologically by the presence of hydropic swelling of the chorionic villi and proliferation of the trophoblasts. It is associated with a substantial risk (10-15%) of developing persistent gestational trophoblastic disease and may even develop into choriocarcinoma eventually. The mechanisms involved in the pathogenesis and progression of hydatidiform mole are poorly understood. Except for the serial assays of serum and urine human chorionic gonadotrophin (hCG), there is no reliable predictor for the early detection of persistent trophoblastic disease.
In this study, we assessed and compared telomerase activity in normal placenta of different gestational stages, hydatidiform mole, and choriocarcinoma using the telomeric repeat amplification protocol (TRAP) assay. 5 The significance of telomerase activity in the development of normal placenta and pathogenesis of gestational trophoblastic disease was investigated. We are particularly interested in hyda-tidiform moles with the potential to produce invasive or even metastatic disease. Such malignant potential may be accompanied by the immortalisation of the trophoblasts in the hydatidiform mole, and this could involve activation of telomerase. The level of telomerase activity was also correlated with clinical follow up to see if high telomerase activity is associated with the development of persistent trophoblastic disease.
Methods

CLINICAL SAMPLES
Thirty five clinically and ultrasonographically suspected cases of hydatidiform mole were suction evacuated. Their gestational age ranged from six to 22 weeks. Thirty placentas of gestational age ranging from six to 20 weeks and five term placentas were obtained after induced abortion by suction evacuation or normal delivery. Fresh chorionic villi and molar vesicles were dissected, selected, snap frozen in liquid nitrogen, and stored at -700C. The rest of the tissue was fixed in formalin. Thirty two of the 35 hydatidiform moles were complete while the other three were partial. Distinction between complete and partial hydatidiform moles was by histological examination using well established diagnostic criteria34 and in situ hybridisation. For confirmation of complete and partial moles by in situ hybridrisation, biotinylated probes specific for the pericentromeric regions of chromosomes 16 and X, as well as part of chromosome Y (American Type Culture Collection, Rockville, Maryland, USA), were used on formalin fixed paraffin embedded tumour tissues.8 The clinical records of patients with a diagnosis of hydatidiform mole, including the postevacuation hCG levels and administration of chemotherapy, were retrieved for assessment.
One Telomerase activity was detected by its ability to add repeats of TTAGGG to its substrate (TS primer) which is an oligonucleotide (5'AATCCGTCGAGCAGAGTT3'). This is a two step reaction. The telomerase present in the extracts would extend the TS primer to generate an extended product. The telomerase product generated was then amplified by polymerase chain reaction (PCR) by including the reverse primer (5'-CCCTTACCCTTAC-C CTTA CCCTTAA-3') in the reaction.
Details of the TRAP assay have been described previously.6 7The assay tubes were prepared by sequestering 0.1 pg of CX primer (5'-CCCTTACCCTTA-CCCTTACCCTT-AA-3') under a wax barrier (Ampliwax; Perkin Elmer Cetus). Each extract was assayed in 25 
Results
Among the 35 hydatidiform moles studie which included 32 complete moles and thr partial moles, 27 regressed spontaneous Eight of the patients had persistently rais hCG level with a diagnosis of persiste trophoblastic disease. Four of these eig patients had documented metastases. Figure 1 shows the telomerase activiti detected in various trophoblastic tissues and choriocarcinoma cell line (JAR) by the TRA eze kit. There were apparent variations of tel merase activities detected in different tropho lastic tissues. Strong telomerase was detect4 in JAR cells. Comparatively weaker telomera activity was detected in case 31, which was first trimester placenta, and in case 29 whii was a complete mole. No telomerase activi was detected in case 30, which was also a cor plete mole. There were variations in the level telomerase detected among individual tr phoblastic tissues. However, owing to t semiquantitative nature of the telomerase ass and other factors that might influence the le, of telomerase activity detected, such heterogeneity of trophoblastic tissues in t specimens or the presence of a telomera inhibitor, no direct comparison of telomera activities among individual trophoblastic t sues was made in this study.
The trophoblastic tissues were classified in those with positive or negative telomera activity and are summarised in Telomerase activation has been demonstrated in many types of human tumours, including those developing in breast,5 nasopharynx,6 stomach,9 prostate,'0 urinary bladder," skin,'2 c cervix,7 and endometrium." These findings suggest that telomerase activation is a crucial step in human carcinogenesis. In tumours of the breast, stomach, and urinary bladder, a y. positive correlation between telomerase activity and clinical stage or pathological grading of the as tumours has been shown. 5 9" Moreover, increased telomerase activity has also been found to be associated with poor prognosis in gastric carcinoma,' meningioma," hepatocellular carcinoma,'" neuroblastoma, '6 and leukaemia.'7 These findings suggest that high levels of telomerase may impart a selective growth advantage in tumour cells, probably thorough stabilisation of telomeres. Lack of correlation between telomerase activity and clinicopathological features. has also been reported,'8 19 which may be related to the difficulties involved in accurate quantitation of telomerase activity, as well as the purity of cancer cells in the surgical specimens. Very few studies have been reported on telomerase activation in trophoblastic diseases. 20 21 As with observations reported in other malignant tumours, the choriocarcinoma sample and the two choriocarcinoma cell lines showed strong telomerase activity. A few cases of hydatidiform mole also showed positive telomerase activity. In fact those cases which later developed into persistent trophoblastic disease and especially those that metastasised tended to have a higher likelihood of telomerase activation. Since telomerase activation plays an important role in sustaining continuous cell division in tumour growth,22 activation of telomerase in hydatidiform mole may facilitate the development of persistent disease. Further study with a larger sample size is, however, necessary to confirm this observation.
We detected telomerase activation in placental tissues, particularly those at an early gestational stage. In another recent study, a higher frequency of telomerase activity was also detected in early placentas compared with term placentas.2' The mechanisms of telomerase expression in the placenta are unclear but may be related to proliferative activity in the early placenta, which is important for invasion and implantation. In endometrial lesions'3 23 and human astrocytomas,2' it has already been shown that telomerase expression is related to proliferative activity. Wright The expression of telomerase activity in normal placentas may be related to other factors. While peripheral blood lymphocytes are low in telomerase activity, reactive lymphocytes in tissues may express it.282 3 Hence lymphocytic infiltration in the placental tissue is another possible source of telomerase. The method used in the extraction of telomerase involved homogenisation of the placental tissue, which prevents identification of the cellular origin of the telomerase detected by the TRAP assay. However, all the placental tissues were examined histologically before extraction for telomerase and we only included those that had minimal contamination with infiltrating lymphocytes. The telomerase positive placental tissues in our study did not contain a significant population of lymphocytes on histological examination. On the other hand, lymphocytic infiltration has been observed in samples with negative telomerase activity, suggesting that infiltrating lymphocytes are unlikely to be the primary source of telomerase in our study. Moreover, by special techniques of isolation and preparation of trophoblasts, Kyo et al have already confirmed that the trophoblastic cells are the major source of telomerase activity in the placenta.20
It is interesting to note that similar telomerase activity was found in both hydatidiform moles and placentas in our study. In a previous study on quantitative analysis of the proliferation index in spontaneous abortion, hydatidiform mole, and choriocarcinoma, we showed that the choriocarcinoma group had a statistically higher proliferation index than spontaneous abortions and hydatidiform moles, while there was no significant difference between spontaneous abortions and hydatidiform moles.' Apparently, hydatidiform mole, being a chromosomally abnormal placenta in nature, has a similar proliferative potential to normal placenta of similar gestational age. We compared the telomerase activation in hydatidiform mole with the expression of proliferation markers such as Ki67, but no significant correlation was observed. In another reported study using a smaller number of cases of gestational trophoblastic disease, hydatidiform mole as a group was found to have higher telomerase activity than normal villi.2' The significance of this finding remains to be confirmed by a larger sample study. Moreover, in complex tissues like the placenta or hydatidiform mole, which are composed of several cell types, accurate quantitation of telomerase activity is unlikely to be straightforward.
In some cases the trophoblastic tissues were negative for telomerase activity, including the early placentas and hydatidiform moles which developed metastases. We took the precaution of ensuring that the lack of telomerase activity was not due to the absence of hydatidiform mole in the specimen tested, since all the samples were checked histologically before extraction for telomerase. Insensitivity of the telomerase assay was also excluded by the presence of activity in the control cell lines and the carcinoma samples.
The inclusion of internal control in the assay also exclude the possibility that the absence of 
